Literature DB >> 30116408

Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta.

Kyoko Imanaka-Yoshida1,2, Ken-Ichi Matsumoto3.   

Abstract

Tenascins are a family of large extracellular matrix (ECM) glycoproteins. Four family members (tenascin-C, -R, -X, and -W) have been identified to date. Each member consists of the same types of structural domains and exhibits time- and tissue-specific expression patterns, suggesting their specific roles in embryonic development and tissue remodeling. Among them, the significant involvement of tenascin-C (TNC) and tenascin-X (TNX) in the progression of vascular diseases has been examined in detail. TNC is strongly up-regulated under pathological conditions, induced by a number of inflammatory mediators and mechanical stress. TNC has diverse functions, particularly in the regulation of inflammatory responses. Recent studies suggest that TNC is involved in the pathophysiology of aneurysmal and dissecting lesions, in part by protecting the vascular wall from destructive mechanical stress. TNX is strongly expressed in vascular walls, and its distribution is often reciprocal to that of TNC. TNX is involved in the stability and maintenance of the collagen network and elastin fibers. A deficiency in TNX results in a form of Ehlers-Danlos syndrome (EDS). Although their exact roles in vascular diseases have not yet been elucidated, TNC and TNX are now being recognized as promising biomarkers for diagnosis and risk stratification of vascular diseases.

Entities:  

Keywords:  aortic aneurysm; aortic dissection; inflammation; tenascin-C; tenascin-X

Year:  2018        PMID: 30116408      PMCID: PMC6094038          DOI: 10.3400/avd.ra.17-00118

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  126 in total

Review 1.  Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects.

Authors:  Manon C Zweers; Alan J Hakim; Rodney Grahame; Joost Schalkwijk
Journal:  Arthritis Rheum       Date:  2004-09

2.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

3.  Distribution of extracellular matrix tenascin-X in sciatic nerves.

Authors:  Ken-Ichi Matsumoto; Hirofumi Sawa; Mami Sato; Yasuko Orba; Kazuo Nagashima; Hiroyoshi Ariga
Journal:  Acta Neuropathol       Date:  2002-06-19       Impact factor: 17.088

Review 4.  Tenascin-C in development and disease of blood vessels.

Authors:  Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Sachiko Miyagawa-Tomita
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

5.  Tenascin-X gene defects and cardiovascular disease.

Authors:  Rachel Morissette; Nazli B McDonnell; Deborah P Merke
Journal:  Med Hypotheses       Date:  2014-03-22       Impact factor: 1.538

6.  α9β1 integrin-mediated signaling serves as an intrinsic regulator of pathogenic Th17 cell generation.

Authors:  Masashi Kanayama; Junko Morimoto; Yutaka Matsui; Masahiro Ikesue; Keiko Danzaki; Daisuke Kurotaki; Koyu Ito; Toshimichi Yoshida; Toshimitsu Uede
Journal:  J Immunol       Date:  2011-10-28       Impact factor: 5.422

7.  Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.

Authors:  Kiyohito Yamamoto; Koji Onoda; Yasuhiro Sawada; Kazuya Fujinaga; Kyoko Imanaka-Yoshida; Hideto Shimpo; Toshimichi Yoshida; Isao Yada
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

Review 8.  Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair.

Authors:  Kyoko Imanaka-Yoshida
Journal:  Circ J       Date:  2012-10-13       Impact factor: 2.993

9.  Tenascin-X induces cell detachment through p38 mitogen-activated protein kinase activation.

Authors:  Shinpei Fujie; Hiroshi Maita; Hiroyoshi Ariga; Ken-ichi Matsumoto
Journal:  Biol Pharm Bull       Date:  2009-10       Impact factor: 2.233

Review 10.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

View more
  5 in total

1.  The expression and role of tenascin C in abdominal aortic aneurysm formation and progression.

Authors:  Felix Nagel; Anne-Kristin Schaefer; Inês Fonseca Gonçalves; Eylem Acar; Andre Oszwald; Philipp Kaiser; Renate Kain; Karola Trescher; Wolf H Eilenberg; Christine Brostjan; David Santer; Attila Kiss; Bruno K Podesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

2.  Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.

Authors:  Daisy Rymen; Marco Ritelli; Nicoletta Zoppi; Valeria Cinquina; Cecilia Giunta; Marianne Rohrbach; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-10-25       Impact factor: 4.096

Review 3.  Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm.

Authors:  Sayantan Jana; Mei Hu; Mengcheng Shen; Zamaneh Kassiri
Journal:  Exp Mol Med       Date:  2019-12-19       Impact factor: 8.718

4.  Tenascin C promotes valvular remodeling in two large animal models of ischemic mitral regurgitation.

Authors:  Ouafa Hamza; Attila Kiss; Anne-Margarethe Kramer; Sandra Trojanek; Dietmar Abraham; Eylem Acar; Felix Nagel; Verena Eva Tretter; Melitta Kitzwögerer; Bruno K Podesser
Journal:  Basic Res Cardiol       Date:  2020-12-01       Impact factor: 17.165

5.  Langerhans cells and SFRP2/Wnt/beta-catenin signalling control adaptation of skin epidermis to mechanical stretching.

Authors:  Joanna K Ledwon; Elbert E Vaca; Chiang C Huang; Lauren J Kelsey; Jennifer L McGrath; Jacek Topczewski; Arun K Gosain; Jolanta M Topczewska
Journal:  J Cell Mol Med       Date:  2022-01-12       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.